Search Results

There are 11452 results for: content related to: Ecstasy and sleep disturbance: Progress towards elucidating a role for the circadian system

  1. You have free access to this content
    Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 4, July 2013, Pages: 289–307, Andrew C. Parrott

    Version of Record online : 23 JUL 2013, DOI: 10.1002/hup.2318

  2. Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 3, May 2015, Pages: 199–207, Luke A. Downey, Helen Sands, Lewis Jones, Angela Clow, Phil Evans, Tobias Stalder and Andrew C. Parrott

    Version of Record online : 21 APR 2015, DOI: 10.1002/hup.2474

  3. A review of the acute subjective effects of MDMA/ecstasy


    Volume 101, Issue 7, July 2006, Pages: 933–947, Chelsea A. Baylen and Harold Rosenberg

    Version of Record online : 24 MAR 2006, DOI: 10.1111/j.1360-0443.2006.01423.x

  4. The effects of ‘ecstasy’ (MDMA) on visuospatial memory performance: findings from a systematic review with meta-analyses

    Human Psychopharmacology: Clinical and Experimental

    Volume 27, Issue 2, March 2012, Pages: 113–138, Philip N. Murphy, Raimondo Bruno, Ida Ryland, Michele Wareing, John E. Fisk, Catharine Montgomery and Joanne Hilton

    Version of Record online : 5 MAR 2012, DOI: 10.1002/hup.1270

  5. MDMA is certainly damaging after 25 years of empirical research: a reply and refutation of Doblin et al. (2014)

    Human Psychopharmacology: Clinical and Experimental

    Volume 29, Issue 2, March 2014, Pages: 109–119, Andrew C. Parrott

    Version of Record online : 3 MAR 2014, DOI: 10.1002/hup.2390

  6. Development and Characterization of a Novel Animal Model of Intermittent MDMA (“Ecstasy”) Exposure during Adolescence

    Annals of the New York Academy of Sciences

    Volume 1139, Issue 1, October 2008, Pages: 151–163, Jerrold S. Meyer, Brian J. Piper and Valerie E. Vancollie

    Version of Record online : 6 OCT 2008, DOI: 10.1196/annals.1432.029

  7. Mental disorders in current and former heavy ecstasy (MDMA) users


    Volume 100, Issue 9, September 2005, Pages: 1310–1319, R. Thomasius, K. U. Petersen, P. Zapletalova, L. Wartberg, D. Zeichner and A. Schmoldt

    Version of Record online : 15 JUL 2005, DOI: 10.1111/j.1360-0443.2005.01180.x

  8. You have free access to this content
    The Dark Side of Ecstasy: Neuropsychiatric Symptoms after Exposure to 3,4-Methylenedioxymethamphetamine

    Basic & Clinical Pharmacology & Toxicology

    Volume 102, Issue 1, January 2008, Pages: 15–24, Sunniva Nyberg Karlsen, Olav Spigset and Lars Slørdal

    Version of Record online : 28 NOV 2007, DOI: 10.1111/j.1742-7843.2007.00159.x

  9. The Variety of Ecstasy/MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions

    The American Journal on Addictions

    Volume 18, Issue 6, November-December 2009, Pages: 452–461, Li-Tzy Wu, Andy C. Parrott, Christopher L. Ringwalt, Chongming Yang and Dan G. Blazer

    Version of Record online : 18 FEB 2010, DOI: 10.3109/10550490903206049

  10. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?


    Volume 101, Issue 3, March 2006, Pages: 348–361, E. Gouzoulis-Mayfrank and J. Daumann

    Version of Record online : 27 FEB 2006, DOI: 10.1111/j.1360-0443.2006.01314.x

  11. MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used ‘Ecstasy’ during pregnancy

    Human Psychopharmacology: Clinical and Experimental

    Volume 29, Issue 1, January 2014, Pages: 1–7, Andrew C. Parrott, Derek G. Moore, John J.D. Turner, Julia Goodwin, Meeyoung O. Min and Lynn T. Singer

    Version of Record online : 14 JAN 2014, DOI: 10.1002/hup.2342

  12. Ecstasy use and self-reported disturbances in sleep

    Human Psychopharmacology: Clinical and Experimental

    Volume 26, Issue 7, October 2011, Pages: 508–516, Rowan P. Ogeil, Shantha M. W. Rajaratnam, James G. Phillips, Jennifer R. Redman and Jillian H. Broadbear

    Version of Record online : 27 SEP 2011, DOI: 10.1002/hup.1233

  13. ‘Ecstasy’ and the use of sleep medications in a general community sample: a 4-year follow-up


    Volume 108, Issue 9, September 2013, Pages: 1640–1648, Robert J. Tait, Amanda George and Sarah Olesen

    Version of Record online : 7 MAY 2013, DOI: 10.1111/add.12200

  14. MDMA and Other “Club Drugs”

    Standard Article

    Handbook of Contemporary Neuropharmacology

    M. Isabel Colado, Esther O'Shea and A. Richard Green

    Published Online : 2 MAR 2007, DOI: 10.1002/9780470101001.hcn039

  15. Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational ‘ecstasy’ users


    Volume 106, Issue 7, July 2011, Pages: 1293–1300, Kate M. Morefield, Michael Keane, Peter Felgate, Jason M. White and Rodney J. Irvine

    Version of Record online : 3 MAY 2011, DOI: 10.1111/j.1360-0443.2011.03399.x

  16. Ecstasy Use, Outcome Expectancies, and Sexual Risk Taking

    Australian Psychologist

    Volume 46, Issue 4, December 2011, Pages: 219–228, Phoebe Proudfoot, Bernd Heubeck, Jeff Ward and Louisa Degenhardt

    Version of Record online : 25 MAR 2011, DOI: 10.1111/j.1742-9544.2010.00016.x

  17. Electrophysiological indices of altered working memory processes in long-term ecstasy users

    Human Psychopharmacology: Clinical and Experimental

    Volume 26, Issue 7, October 2011, Pages: 488–497, Claire Nulsen, Allison Fox and Geoff Hammond

    Version of Record online : 25 SEP 2011, DOI: 10.1002/hup.1231

  18. The Drug Information and Monitoring System (DIMS) in the Netherlands: Implementation, results, and international comparison

    Drug Testing and Analysis

    Volume 3, Issue 9, September 2011, Pages: 621–634, Tibor M. Brunt and Raymond J.M. Niesink

    Version of Record online : 6 SEP 2011, DOI: 10.1002/dta.323

  19. Contextualising psychological distress among regular ecstasy users: The importance of sociodemographic factors and patterns of drug use

    Drug and Alcohol Review


    Version of Record online : 19 JAN 2010, DOI: 10.1111/j.1465-3362.2009.00159.x

  20. The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 2, August 2011, Pages: 246–255, CM Hysek, LD Simmler, M Ineichen, E Grouzmann, MC Hoener, R Brenneisen, J Huwyler and ME Liechti

    Version of Record online : 15 JUN 2011, DOI: 10.1038/clpt.2011.78